×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Slagel Dean

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CARACara Therapeutics, Inc.Slagel DeanDirectorJun 29, 2017Sale$25.87250,0006,468,5641,085,200Jul 03, 2017, 05:53 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorDec 31, 2015Sale$17.0012,776217,1921,345,562Jan 12, 2016, 07:00 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorJan 05, 2016Sale$17.0131,224531,1201,314,338Jan 12, 2016, 07:00 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorJan 05, 2016Sale$17.0131,224531,1201,314,338Jan 05, 2016, 04:54 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorDec 31, 2015Sale$17.0012,776217,1921,345,562Jan 05, 2016, 04:54 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorMay 15, 2015Sale$10.0073,600736,0001,473,549May 19, 2015, 05:11 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorMay 18, 2015Sale$10.0482,945832,7681,390,604May 19, 2015, 05:11 PM
CARACara Therapeutics, Inc.Slagel DeanDirectorMay 19, 2015Sale$10.0032,266322,6601,358,338May 19, 2015, 05:11 PM